{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T01:52:52Z","timestamp":1771725172673,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100002152","name":"International Trachoma Initiative","doi-asserted-by":"crossref","award":["1491"],"award-info":[{"award-number":["1491"]}],"id":[{"id":"10.13039\/100002152","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002152","name":"International Trachoma Initiative","doi-asserted-by":"crossref","award":["1491"],"award-info":[{"award-number":["1491"]}],"id":[{"id":"10.13039\/100002152","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002152","name":"International Trachoma Initiative","doi-asserted-by":"crossref","award":["1491"],"award-info":[{"award-number":["1491"]}],"id":[{"id":"10.13039\/100002152","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002152","name":"International Trachoma Initiative","doi-asserted-by":"crossref","award":["1491"],"award-info":[{"award-number":["1491"]}],"id":[{"id":"10.13039\/100002152","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A serologic test for antibodies to chlamydia may be a useful tool for trachoma surveillance. However, little is known about the longitudinal stability of antibody status, especially following Mass Drug Administration (MDA), which is critical to understanding serostatus in trachoma-endemic areas. A longitudinal cohort of 1908 children ages 1\u20139\u00a0years in Tanzania from 50 communities were followed at baseline and for 6\u00a0months after MDA. They were evaluated for clinical trachoma, conjunctival swabs were tested for chlamydial infection using GeneXpert platform, and blood spots were collected on filter paper and dried to test for antibodies to Chlamydia trachomatis pgp3 using the Luminex platform. 6.3% of children in the study had infection, and coverage with MDA was 97%. 670 (35%) were sero-positive for pgp3 antibodies at baseline, and 4.0% of these seroreverted to negative following MDA. Of those seronegative at baseline, 3.6% seroconverted. The individual change in log median fluorescence intensity(MFI-BG) values was -0.15 overall (p\u2009&lt;\u2009.001). Seroconversion rates were lower following MDA and seroreversion rates were slightly higher compared to rates in this same cohort in the absence of MDA. MDA has a small effect on reduction of MFI-BG.<\/jats:p>","DOI":"10.1038\/s41598-020-71833-x","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T10:03:22Z","timestamp":1600250602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children"],"prefix":"10.1038","volume":"10","author":[{"given":"Sheila K.","family":"West","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harran","family":"Mkocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte A.","family":"Gaydos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,16]]},"reference":[{"issue":"9960","key":"71833_CR1","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/S0140-6736(13)62182-0","volume":"384","author":"HR Taylor","year":"2014","unstructured":"Taylor, H. R., Burton, M. J., Haddad, D., West, S. & Wright, H. Trachoma. Lancet 384(9960), 2142\u20132152. https:\/\/doi.org\/10.1016\/S0140-6736(13)62182-0 (2014).","journal-title":"Lancet"},{"key":"71833_CR2","unstructured":"World_Health_Assembly. WHA51.11 Global Elimnation of Blinding Trachoma (1998)."},{"key":"71833_CR3","unstructured":"World_Health_Organization. Technical Consultation on Trachoma Surveillance. Meeting Report. (World Health Organization Press, Geneva, Switzerland, 2015)."},{"issue":"2","key":"71833_CR4","doi-asserted-by":"publisher","first-page":"e0003555","DOI":"10.1371\/journal.pntd.0003555","volume":"9","author":"DL Martin","year":"2015","unstructured":"Martin, D. L. et al. Serology for trachoma surveillance after cessation of mass drug administration. PLoS Negl. Trop. Dis. 9(2), e0003555. https:\/\/doi.org\/10.1371\/journal.pntd.0003555 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"6","key":"71833_CR5","doi-asserted-by":"publisher","first-page":"e2115","DOI":"10.1371\/journal.pntd.0002115","volume":"7","author":"EM Harding-Esch","year":"2013","unstructured":"Harding-Esch, E. M. et al. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia. PLoS Negl. Trop. Dis. 7(6), e2115. https:\/\/doi.org\/10.1371\/journal.pntd.0002115 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"71833_CR6","doi-asserted-by":"publisher","first-page":"e0004352","DOI":"10.1371\/journal.pntd.0004352","volume":"10","author":"SK West","year":"2016","unstructured":"West, S. K. et al. Can we use antibodies to chlamydia trachomatis as a surveillance tool for national trachoma control programs? Results from a district survey. PLoS Negl. Trop. Dis. 10(1), e0004352. https:\/\/doi.org\/10.1371\/journal.pntd.0004352 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"11","key":"71833_CR7","doi-asserted-by":"publisher","first-page":"e1873","DOI":"10.1371\/journal.pntd.0001873","volume":"6","author":"EB Goodhew","year":"2012","unstructured":"Goodhew, E. B. et al. CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl. Trop. Dis. 6(11), e1873. https:\/\/doi.org\/10.1371\/journal.pntd.0001873 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"71833_CR8","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1038\/s41598-018-21127-0","volume":"8","author":"SK West","year":"2018","unstructured":"West, S. K. et al. Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area. Sci. Rep. 8(1), 3520. https:\/\/doi.org\/10.1038\/s41598-018-21127-0 (2018).","journal-title":"Sci. Rep."},{"key":"71833_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/1471-2334-14-216","volume":"14","author":"EB Goodhew","year":"2014","unstructured":"Goodhew, E. B. et al. Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration. BMC Infect. Dis. 14, 216. https:\/\/doi.org\/10.1186\/1471-2334-14-216 (2014).","journal-title":"BMC Infect. Dis."},{"issue":"6","key":"71833_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/09286586.2016.1238947","volume":"23","author":"AM Ervin","year":"2016","unstructured":"Ervin, A. M. et al. Surveillance and azithromycin treatment for newcomers and travelers Evaluation (ASANTE) trial: design and baseline characteristics. Ophthalmic. Epidemiol. 23(6), 347\u2013353. https:\/\/doi.org\/10.1080\/09286586.2016.1238947 (2016).","journal-title":"Ophthalmic. Epidemiol."},{"key":"71833_CR11","first-page":"477","volume":"65","author":"B Thylefors","year":"1987","unstructured":"Thylefors, B., Dawson, C., Jones, B. R., West, S. K. & Taylor, H. R. A simple system for the assessment of trachoma and its complications. Bull. WHO. 65, 477\u2013483 (1987).","journal-title":"Bull. WHO."},{"issue":"4","key":"71833_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.diagmicrobio.2013.08.005","volume":"77","author":"L Dize","year":"2013","unstructured":"Dize, L., West, S., Quinn, T. C. & Gaydos, C. A. Pooling ocular swab specimens from Tanzania for testing by Roche Amplicor and Aptima Combo 2 assays for the detection of Chlamydia trachomatis: accuracy and cost-savings. Diagn. Microbiol. Infect. Dis. 77(4), 289\u2013291. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.08.005 (2013).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"2","key":"71833_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.diagmicrobio.2014.11.010","volume":"81","author":"L Dize","year":"2015","unstructured":"Dize, L., West, S. K., Mkocha, H., Quinn, T. C. & Gaydos, C. A. Evaluation of pooled ocular and vaginal swabs by the Cepheid GeneXpert CT\/NG assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae compared to the GenProbe Aptima Combo 2 Assay. Diagn. Microbiol. Infect. Dis. 81(2), 102\u2013104. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.11.010 (2015).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"9","key":"71833_CR14","doi-asserted-by":"publisher","first-page":"e0005003","DOI":"10.1371\/journal.pntd.0005003","volume":"10","author":"AI Zambrano","year":"2016","unstructured":"Zambrano, A. I. et al. The World Health Organization Recommendations for Trachoma Surveillance, Experience in Nepal and added benefit of testing for antibodies to chlamydia trachomatis pgp3 protein: NESTS study. PLoS Negl. Trop. Dis. 10(9), e0005003. https:\/\/doi.org\/10.1371\/journal.pntd.0005003 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"8","key":"71833_CR15","doi-asserted-by":"publisher","first-page":"e2415","DOI":"10.1371\/journal.pntd.0002415","volume":"7","author":"SK West","year":"2013","unstructured":"West, S. K. et al. A randomized trial of two coverage targets for mass treatment with azithromycin for trachoma. PLoS Negl. Trop. Dis. 7(8), e2415. https:\/\/doi.org\/10.1371\/journal.pntd.0002415 (2013).","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71833-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71833-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71833-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:40:47Z","timestamp":1670355647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71833-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,16]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["71833"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-71833-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,16]]},"assertion":[{"value":"13 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15225"}}